162 related articles for article (PubMed ID: 31877302)
1. Ubiquitin-like protein FAT10 promotes osteosarcoma growth by modifying the ubiquitination and degradation of YAP1.
Yi X; Deng X; Zhao Y; Deng B; Deng J; Fan H; Du Y; Hao L
Exp Cell Res; 2020 Feb; 387(2):111804. PubMed ID: 31877302
[TBL] [Abstract][Full Text] [Related]
2. Knockdown of YAP1 inhibits the proliferation of osteosarcoma cells in vitro and in vivo.
Yang Z; Zhang M; Xu K; Liu L; Hou WK; Cai YZ; Xu P; Yao JF
Oncol Rep; 2014 Sep; 32(3):1265-72. PubMed ID: 24993351
[TBL] [Abstract][Full Text] [Related]
3. Ubiquitin-Like Protein FAT10 Promote Colorectal Cancer Progression by Affecting the Ubiquitination of Capn4.
Cheng F; Yuan L; Wu Z; Li X; Xia W; Huang Z; Li Z; Mao S; Shen W
Dig Dis Sci; 2023 Aug; 68(8):3312-3323. PubMed ID: 37310562
[TBL] [Abstract][Full Text] [Related]
4. NUB1 and FAT10 Proteins as Potential Novel Biomarkers in Cancer: A Translational Perspective.
Arshad M; Abdul Hamid N; Chan MC; Ismail F; Tan GC; Pezzella F; Tan KL
Cells; 2021 Aug; 10(9):. PubMed ID: 34571823
[TBL] [Abstract][Full Text] [Related]
5. Ubiquitin-like protein FAT10 promotes osteosarcoma glycolysis and growth by upregulating PFKFB3 via stabilization of EGFR.
Deng X; Deng J; Yi X; Zou Y; Liu H; Li C; Deng B; Fan H; Hao L
Am J Cancer Res; 2020; 10(7):2066-2082. PubMed ID: 32775001
[TBL] [Abstract][Full Text] [Related]
6. Ubiquitin-like protein FAT10 promotes bladder cancer progression by stabilizing survivin.
Dong D; Jiang W; Lei J; Chen L; Liu X; Ge J; Che B; Xi X; Shao J
Oncotarget; 2016 Dec; 7(49):81463-81473. PubMed ID: 27806337
[TBL] [Abstract][Full Text] [Related]
7. ROCK2 promotes osteosarcoma growth and metastasis by modifying PFKFB3 ubiquitination and degradation.
Deng X; Yi X; Deng J; Zou Y; Wang S; Shan W; Liu P; Zhang Z; Chen L; Hao L
Exp Cell Res; 2019 Dec; 385(2):111689. PubMed ID: 31678169
[TBL] [Abstract][Full Text] [Related]
8. TEAD1 mediates the oncogenic activities of Hippo-YAP1 signaling in osteosarcoma.
Chai J; Xu S; Guo F
Biochem Biophys Res Commun; 2017 Jun; 488(2):297-302. PubMed ID: 28483529
[TBL] [Abstract][Full Text] [Related]
9. Ubiquitin-like protein FAT10 promotes the invasion and metastasis of hepatocellular carcinoma by modifying β-catenin degradation.
Yuan R; Wang K; Hu J; Yan C; Li M; Yu X; Liu X; Lei J; Guo W; Wu L; Hong K; Shao J
Cancer Res; 2014 Sep; 74(18):5287-300. PubMed ID: 25056121
[TBL] [Abstract][Full Text] [Related]
10. Silencing FAT10 inhibits metastasis of osteosarcoma.
Ma C; Zhang Z; Cui Y; Yuan H; Wang F
Int J Oncol; 2016 Aug; 49(2):666-74. PubMed ID: 27279480
[TBL] [Abstract][Full Text] [Related]
11. BRCA1/BARD1-dependent ubiquitination of NF2 regulates Hippo-YAP1 signaling.
Verma S; Yeddula N; Soda Y; Zhu Q; Pao G; Moresco J; Diedrich JK; Hong A; Plouffe S; Moroishi T; Guan KL; Verma IM
Proc Natl Acad Sci U S A; 2019 Apr; 116(15):7363-7370. PubMed ID: 30918126
[TBL] [Abstract][Full Text] [Related]
12. The role and clinical significance of YES-associated protein 1 in human osteosarcoma.
Zhang YH; Li B; Shen L; Shen Y; Chen XD
Int J Immunopathol Pharmacol; 2013; 26(1):157-67. PubMed ID: 23527718
[TBL] [Abstract][Full Text] [Related]
13. miR-375 is involved in Hippo pathway by targeting YAP1/TEAD4-CTGF axis in gastric carcinogenesis.
Kang W; Huang T; Zhou Y; Zhang J; Lung RWM; Tong JHM; Chan AWH; Zhang B; Wong CC; Wu F; Dong Y; Wang S; Yang W; Pan Y; Chak WP; Cheung AHK; Pang JCS; Yu J; Cheng ASL; To KF
Cell Death Dis; 2018 Jan; 9(2):92. PubMed ID: 29367737
[TBL] [Abstract][Full Text] [Related]
14. The Ubiquitin-like Protein FAT10 Stabilizes eEF1A1 Expression to Promote Tumor Proliferation in a Complex Manner.
Liu X; Chen L; Ge J; Yan C; Huang Z; Hu J; Wen C; Li M; Huang D; Qiu Y; Hao H; Yuan R; Lei J; Yu X; Shao J
Cancer Res; 2016 Aug; 76(16):4897-907. PubMed ID: 27312528
[TBL] [Abstract][Full Text] [Related]
15. STUB1 suppresseses tumorigenesis and chemoresistance through antagonizing YAP1 signaling.
Tang DE; Dai Y; Lin LW; Xu Y; Liu DZ; Hong XP; Jiang HW; Xu SH
Cancer Sci; 2019 Oct; 110(10):3145-3156. PubMed ID: 31393050
[TBL] [Abstract][Full Text] [Related]
16. Long noncoding RNA APTR contributes to osteosarcoma progression through repression of miR-132-3p and upregulation of yes-associated protein 1.
Guan H; Shang G; Cui Y; Liu J; Sun X; Cao W; Wang Y; Li Y
J Cell Physiol; 2019 Jun; 234(6):8998-9007. PubMed ID: 30317613
[TBL] [Abstract][Full Text] [Related]
17. FAT10 promotes the progression of bladder cancer by upregulating HK2 through the EGFR/AKT pathway.
Zou Y; Du Y; Cheng C; Deng X; Shi Z; Lu X; Hu H; Qiu J; Jiang W
Exp Cell Res; 2021 Jan; 398(1):112401. PubMed ID: 33253711
[TBL] [Abstract][Full Text] [Related]
18. miR-1285-3p is a potential prognostic marker in human osteosarcoma and functions as a tumor suppressor by targeting YAP1.
Hu XH; Dai J; Shang HL; Zhao ZX; Hao YD
Cancer Biomark; 2019; 25(1):1-10. PubMed ID: 31006663
[TBL] [Abstract][Full Text] [Related]
19. FAT10ylation as a signal for proteasomal degradation.
Schmidtke G; Aichem A; Groettrup M
Biochim Biophys Acta; 2014 Jan; 1843(1):97-102. PubMed ID: 23333871
[TBL] [Abstract][Full Text] [Related]
20. Degradation of FAT10 by the 26S proteasome is independent of ubiquitylation but relies on NUB1L.
Schmidtke G; Kalveram B; Groettrup M
FEBS Lett; 2009 Feb; 583(3):591-4. PubMed ID: 19166848
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
